EBRC In Translation

29. Commercializing CRISPR w/ Janice Chen

July 01, 2024 EBRC SPA Episode 29
29. Commercializing CRISPR w/ Janice Chen
EBRC In Translation
More Info
EBRC In Translation
29. Commercializing CRISPR w/ Janice Chen
Jul 01, 2024 Episode 29
EBRC SPA

In this episode, we speak with Janice Chen, co-founder and CTO of Mammoth Biosciences. From her PhD work in Jennifer Doudna's lab to co-founding a biotech startup, Dr. Chen discusses her journey of translating scientific discoveries into real-world applications. Learn about the development of CRISPR-based diagnostics, including a rapid COVID-19 test, and gain insights into the evolving landscape of gene editing therapeutics. Dr. Chen also offers valuable advice for scientists looking to bridge the gap between academia and industry.

For more information about EBRC, visit our website at ebrc.org. If you are interested in getting involved with the EBRC Student and Postdoc Association, fill out a membership application for graduate students and postdocs or for undergraduates and join today!

Episode transcripts are the unedited output from Whisper and likely contain errors.

Show Notes

In this episode, we speak with Janice Chen, co-founder and CTO of Mammoth Biosciences. From her PhD work in Jennifer Doudna's lab to co-founding a biotech startup, Dr. Chen discusses her journey of translating scientific discoveries into real-world applications. Learn about the development of CRISPR-based diagnostics, including a rapid COVID-19 test, and gain insights into the evolving landscape of gene editing therapeutics. Dr. Chen also offers valuable advice for scientists looking to bridge the gap between academia and industry.

For more information about EBRC, visit our website at ebrc.org. If you are interested in getting involved with the EBRC Student and Postdoc Association, fill out a membership application for graduate students and postdocs or for undergraduates and join today!

Episode transcripts are the unedited output from Whisper and likely contain errors.